Tier C

Niacin (Nicotinic Acid · Vitamin B3 acid form)

Also known as: Nicotinic Acid · Vitamin B3 (acid form) · Vitamin PP (acid form) · Niaspan (Rx ER form)

2 PMID anchor · METABOLISM · CARDIO · SKIN · Last reviewed 2026-06-02

Mechanism of action

  • HM74A/GPR109A agonism
  • NAD+ precursor
  • Lipid management (HDL+ / TG-)
  • Adiponectin-mediated insulin sensitivity

Molecular + tissue targets

  • GPR109A receptor
  • NAD+ pool
  • Liver lipoprotein metabolism

Dosage range

14-18 mg/day RDA (B3 deficiency prevention) · 500-2000 mg/day Rx ER Niaspan (Tier C · prescription only)

Safety notes

Flushing common at > 50 mg/day acute · hepatotoxicity at sustained > 3 g/day · UL 35 mg/day (NIH-ODS) for non-prescription · Rx Niaspan AIM-HIGH 2011 (PMID 22085343) + HPS2-THRIVE 2014 (PMID 25014686) showed no incremental benefit + adverse signal on statin background

Cross-market regulatory status

🇺🇸 FDA

GRAS (vitamin B3 acid form low dose) · Rx Niaspan for hyperlipidemia

🇪🇺 EFSA

Reg 432/2012 authorized health claims · 6 niacin claims (vitamin B3 family)

🇧🇷 ANVISA

IN 28/2018 Anexo V "niacina" · 4 functional claims (pele · mucosas · metabolismo energético · metabolismo de proteínas/carboidratos/gorduras) · UL 35 mg/day non-prescription

Authorized claims · verbatim (10)

Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.

🇪🇺 EFSA · 6 claims

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2009;7(9):1224

Niacin contributes to normal energy-yielding metabolism

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim "SOURCE OF [VITAMIN/S]" threshold (15% of NRV per 100 g/ml or per portion; niacin NRV = 16 mg)

Authorized 2012

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2009;7(9):1224

Niacin contributes to normal functioning of the nervous system

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim threshold

Authorized 2012

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2010;8(10):1757

Niacin contributes to normal psychological function

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim threshold

Authorized 2012

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2009;7(9):1224

Niacin contributes to the maintenance of normal mucous membranes

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim threshold

Authorized 2012

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2009;7(9):1224 + 2010;8(10):1757

Niacin contributes to the maintenance of normal skin

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim threshold

Authorized 2012

Reg 432/2012 Annex · authorized health claim · EFSA Journal 2010;8(10):1757

Niacin contributes to the reduction of tiredness and fatigue

Conditions: Food must be at least a source of niacin per Reg 1924/2006 nutrition claim threshold

Authorized 2012

🇧🇷 ANVISA · 4 claims

IN 28/2018 Anexo V · alegação funcional autorizada

A niacina auxilia no metabolismo energético.

Conditions: Alegação restrita aos suplementos alimentares cuja quantidade de niacina atenda aos valores mínimos estabelecidos no Anexo III (≥ 2.4 mg/dia adultos ≥ 19 anos)

Authorized 2018

IN 28/2018 Anexo V · alegação funcional autorizada

A niacina auxilia no metabolismo de proteínas, carboidratos e gorduras.

Conditions: Alegação restrita aos suplementos alimentares cuja quantidade de niacina atenda aos valores mínimos estabelecidos no Anexo III (≥ 2.4 mg/dia adultos ≥ 19 anos)

Authorized 2018

IN 28/2018 Anexo V · alegação funcional autorizada

A niacina contribui para a manutenção da pele.

Conditions: Alegação restrita aos suplementos alimentares cuja quantidade de niacina atenda aos valores mínimos estabelecidos no Anexo III (≥ 2.4 mg/dia adultos ≥ 19 anos)

Authorized 2018

IN 28/2018 Anexo V · alegação funcional autorizada

A niacina auxilia na manutenção de mucosas.

Conditions: Alegação restrita aos suplementos alimentares cuja quantidade de niacina atenda aos valores mínimos estabelecidos no Anexo III (≥ 2.4 mg/dia adultos ≥ 19 anos)

Authorized 2018

Common use cases

  • cardiovascular lipid management (Rx prescription only)
  • NAD+ precursor (low dose RDA)
  • pellagra treatment
Ask Agent Axor